» Articles » PMID: 24589413

Hypoxia Promotes Vasculogenic Mimicry Formation by Inducing Epithelial-mesenchymal Transition in Ovarian Carcinoma

Overview
Journal Gynecol Oncol
Date 2014 Mar 5
PMID 24589413
Citations 84
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The functions of hypoxia and subsequent hypoxia-inducible factor-1α (HIF-1α) activation in vasculogenic mimicry (VM) are currently unclear. This study aimed to investigate the effects of hypoxia on VM formation in ovarian cancer, and explore the possible mechanism involved.

Methods: The expression levels of HIF-1α, E-cadherin, vimentin, Twist1, Slug, and VE-cadherin proteins were analyzed by immunohistochemistry in 71 specimens of epithelial ovarian cancer. The results were correlated with VM and survival analysis. We used a well-established in vitro model of a three-dimensional culture to compare VM formation under hypoxia and normoxia in ovarian cancer cell lines SKOV3 and OVCAR3. To explore the potential mechanism, we examined the effects of hypoxia on the mRNA and protein expression levels of both E-cadherin and vimentin.

Results: HIF-1α expression was correlated with loss of E-cadherin expression and up-regulated vimentin expression in 11 of the 18 VM-positive patients. Ovarian cancer with evidence of VM was significantly more likely to have high Twist1, Slug, and VE-cadherin expression levels. VM was observed in vitro under hypoxia. The ovarian cancer cells presented morphological epithelial-mesenchymal transition (EMT)-like changes (more fibroblastoid morphology and loss of cellular cohesiveness) under hypoxic conditions. The mRNA and protein levels demonstrated the induction of EMT after hypoxia. Clinicopathological analysis revealed that both VM and HIF-1α expression levels presented shorter survival durations.

Conclusions: Hypoxia contributed to VM formation by inducing EMT. These results may offer new insights for consideration in ovarian cancer treatment strategies.

Citing Articles

IL-1β in Neoplastic Disease and the Role of Its Tumor-Derived Form in the Progression and Treatment of Metastatic Prostate Cancer.

Oyende Y, Taus L, Fatatis A Cancers (Basel). 2025; 17(2).

PMID: 39858071 PMC: 11763358. DOI: 10.3390/cancers17020290.


ESM1 enhances fatty acid synthesis and vascular mimicry in ovarian cancer by utilizing the PKM2-dependent warburg effect within the hypoxic tumor microenvironment.

Zhang J, Ouyang F, Gao A, Zeng T, Li M, Li H Mol Cancer. 2024; 23(1):94.

PMID: 38720298 PMC: 11077861. DOI: 10.1186/s12943-024-02009-8.


Therapeutic potential of vasculogenic mimicry in urological tumors.

Lin X, Long S, Yan C, Zou X, Zhang G, Zou J Front Oncol. 2023; 13:1202656.

PMID: 37810976 PMC: 10551447. DOI: 10.3389/fonc.2023.1202656.


Pharmacological Activity of Matrine in Inhibiting Colon Cancer Cells VM Formation, Proliferation, and Invasion by Downregulating Claudin-9 Mediated EMT Process and MAPK Signaling Pathway.

Du Q, Lin Y, Ding C, Wu L, Xu Y, Feng Q Drug Des Devel Ther. 2023; 17:2787-2804.

PMID: 37719361 PMC: 10504061. DOI: 10.2147/DDDT.S417077.


Unlocking the Potential of Mesenchymal Stem Cells in Gynecology: Where Are We Now?.

Erceg Ivkosic I, Fures R, Cosic V, Mikelin N, Bulic L, Dobranic D J Pers Med. 2023; 13(8).

PMID: 37623503 PMC: 10455325. DOI: 10.3390/jpm13081253.